Lot-verified

Tesamorelin (GHRH Analog) – Lyophilized Peptide Vial

Price range: $60.00 through $175.00

COA verified
Batch
Tesa-0012-02
Purity
99.536%
Tested by
TrustPointe Analytics LLC
Test date
19 Feb 2026
View certificate

Description

Tesamorelin is a stabilized analogue of the growth hormone-releasing factor (GRF). It is widely studied for its ability to target visceral adipose tissue and regulate lipid metabolism through the GHRH pathway.

Mechanism of Action As a GHRH agonist, Tesamorelin binds to specific receptors on pituitary somatotrophs, triggering the pulsatile release of growth hormone. This mechanism makes it a key subject in studies regarding abdominal fat reduction and metabolic health in non-clinical settings.

Quality Assurance

  • Sequence: Trans-3-hexenoyl-[Tyr1] hGRF (1-44) NH2

  • Purity: >99% by HPLC

  • Form: Sterile Lyophilized Powder

  • Storage: Store at -20°C (lyophilized) or 4°C (reconstituted).

FOR RESEARCH USE ONLY:

This product is sold strictly as a chemical reference standard for in-vitro laboratory research purposes only. It is not intended for human or animal consumption, injection, or administration of any kind. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Bodily introduction into humans or animals is strictly prohibited. For use by qualified research professionals only.

Additional information

MG

5, 10, 15, 20

Research reference

A synthetic GHRH (1-44) analogue bearing a trans-3-hexenoyl group at the N-terminus, which increases resistance to enzymatic degradation. Used as a stable GHRH reference standard.

Class
GHRH (1-44) analogue
CAS
218949-48-5
Formula
C221H366N72O67S
Storage
Lyophilized: -20°C. Reconstituted: 2-8°C.

Research use only. Sold as a chemical reference standard for in-vitro laboratory research. Not for human or veterinary use, and not a drug, food or cosmetic.